SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-050374
Filing Date
2014-08-04
Accepted
2014-08-04 18:17:50
Documents
1
Period of Report
2014-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2137
  Complete submission text file 0001209191-14-050374.txt   3990
Mailing Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116
Business Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116 617-600-4164
EPIRUS Biopharmaceuticals, Inc. (Issuer) CIK: 0001135906 (see all company filings)

IRS No.: 043514457 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address GUIHAU NORTH ROAD, NO. 132 GONGBEI ZHUHAI CITY F4 519020
Business Address GUIHAU NORTH ROAD, NO. 132 GONGBEI ZHUHAI CITY F4 519020 0756-8135105
Livzon MABPharm Inc. (Reporting) CIK: 0001615554 (see all company filings)

State of Incorp.: F4 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-51171 | Film No.: 141014222